$ Value
$0
Shares
17,437
Price
$0
Filed
Mar 13
Insider
Name
Inglis Tiffany Eul Davis
Title
Chief Medical Officer
CIK
0002091798
Roles
Transaction Details
Transaction Date
2026-03-12
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
92,437
Footnotes
Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/16 of the original grant amount vests in quarterly installments for four years following the vesting commencement date, which is March 10, 2026, subject to the Reporting Person continuing to provide services to the issuer. | These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 10, 2026, subject to the Reporting Person continuing to provide services to the issuer.
Filing Info
Inglis Tiffany Eul Davis's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-12 | SERA | A | $0 |
| 2026-03-12 | SERA | A | $0 |
| 2025-10-15 | SERA | A | $0 |
| 2025-10-15 | SERA | A | $0 |
Other Insiders at SERA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lawrence Sandra AJ | — | $3K | 2026-03-06 |
|
Harrison Robert Gardner
Chief Information Officer
|
— | $19K | 2026-03-11 |
| Kamdar Kim P. | — | — | 2026-02-04 |
|
Jackson Benjamin
General Counsel
|
— | $8K | 2026-03-12 |
|
Boniface John J.
Chief Scientific Officer
|
— | $9K | 2026-03-11 |
|
Kearney Paul
Chief Data Officer
|
— | $7K | 2026-03-11 |
|
Lindgardt Zhenya
Chief Executive Officer
|
— | $49K | 2026-03-12 |
|
Aerts Austin
Chief Financial Officer
|
— | $15K | 2026-03-12 |
|
Anderson Dyaarl Lee Jr.
Chief Commercial Officer
|
— | — | 2026-03-12 |
|
Inglis Tiffany Eul Davis
Chief Medical Officer
|
— | — | 2026-03-12 |